Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase I trial of taxotere, cisplatin, and CPT-11 (TPC) in advanced solid tumor malignancies

Phase I trial of taxotere, cisplatin, and CPT-11 (TPC) in advanced solid tumor malignancies. Journal of Clinical Oncology, ASCO Annual Meeting Proceedings. 2001.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.